Loading...
UCB SA
UCB.BR•EURONEXT
HealthcareBiotechnology
€162.75
€0.05(0.03%)
UCB SA (UCB.BR) Financial Performance & Statements
Review UCB SA’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
17.14%
↑ 17.14%
Operating Income Growth
119.21%
↑ 119.21%
Net Income Growth
210.50%
↑ 210.50%
Operating Cash Flow Growth
63.21%
↑ 63.21%
Operating Margin
13.39%
↑ 13.39%
Gross Margin
69.64%
↑ 69.64%
Net Profit Margin
17.31%
↑ 17.31%
ROE
11.22%
↑ 11.22%
ROIC
5.96%
↑ 5.96%
UCB SA (UCB.BR) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for UCB SA stock.
| Metric | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|
| Revenue | $2.79B | $2.66B | $2.59B | $2.59B |
| Cost of Revenue | $851.00M | $1.009B | $901.00M | $925.00M |
| Gross Profit | $1.94B | $1.65B | $1.69B | $1.67B |
| Gross Profit Ratio | $0.70 | $0.62 | $0.65 | $0.64 |
| R&D Expenses | $789.00M | $871.00M | $759.00M | $872.00M |
| SG&A Expenses | $1.07B | $863.00M | $758.00M | $773.00M |
| Operating Expenses | $1.62B | $1.48B | $1.21B | $1.55B |
| Total Costs & Expenses | $2.47B | $2.49B | $2.11B | $2.47B |
| Interest Income | $15.00M | $31.00M | $16.00M | $0.00 |
| Interest Expense | $92.00M | $115.00M | $95.00M | $64.00M |
| Depreciation & Amortization | $318.00M | $376.00M | $315.00M | $322.00M |
| EBITDA | $644.00M | $541.00M | $728.00M | $416.00M |
| EBITDA Ratio | $0.23 | $0.21 | $0.31 | $0.17 |
| Operating Income | $323.00M | $176.00M | $479.00M | $118.00M |
| Operating Income Ratio | $0.12 | $0.07 | $0.19 | $0.05 |
| Other Income/Expenses (Net) | -$77.00M | -$84.00M | -$78.00M | -$88.00M |
| Income Before Tax | $246.00M | $40.00M | $401.00M | $30.00M |
| Income Before Tax Ratio | $0.09 | $0.02 | $0.15 | $0.01 |
| Income Tax Expense | $38.00M | $8.00M | $90.00M | $9.00M |
| Net Income | $208.00M | $32.00M | $311.00M | $19.00M |
| Net Income Ratio | $0.07 | $0.01 | $0.12 | $0.007 |
| EPS | $1.10 | $0.17 | $1.64 | $0.10 |
| Diluted EPS | $1.07 | $0.16 | $1.60 | $0.10 |
| Weighted Avg Shares Outstanding | $189.89M | $189.78M | $189.26M | $189.59M |
| Weighted Avg Shares Outstanding (Diluted) | $195.007M | $199.62M | $194.75M | $192.18M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan